Cardiol Therapeutics Inc.

Drug Manufacturers - Specialty & Generic • Healthcare • Oakville, ON, United States • CRDL (NCM)

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

289 910 0850 2265 Upper Middle Road East, Oakville, ON L6H 0G5, Canada

Stock Performance (90 Days)

Data through Dec 30, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Cardiol Therapeutics’ stock down 20% on Phase II CardiolRx failure - Clinical Trials Arena

Clinical Trials Arena • Aug 7

Cardiol Therapeutics (TSE:CRDL) Stock Price Down 0.7% - Here's Why - MarketBeat

MarketBeat • Dec 24

Cardiol Therapeutics (NASDAQ: CRDL) extends cash runway to Q3 2027 after $11.4M financing - Stock Titan

Stock Titan • Oct 21

Should you sell your Cardiol Therapeutics stock? - Cantech Letter

Cantech Letter • Dec 4

H.C. Wainwright reaffirms Buy rating on Cardiol Therapeutics stock at $9 target - Investing.com Nigeria

Investing.com Nigeria • Dec 2

Other Drug Manufacturers - Specialty & Generic Companies

View All →

Elanco Animal Health Inc.

Takeda Pharmaceutical Co. Ltd.

$47.02B market cap

Haleon PLC

$44.93B market cap

TEVA Pharmaceutical Industries Ltd.

$32.82B market cap

Frequently Asked Questions

Has Cardiol Therapeutics Inc. had layoffs?

No layoff events have been recorded for Cardiol Therapeutics Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Cardiol Therapeutics Inc. have?

Cardiol Therapeutics Inc. has approximately 18 employees.

What industry is Cardiol Therapeutics Inc. in?

Cardiol Therapeutics Inc. operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.

Is Cardiol Therapeutics Inc. a publicly traded company?

Yes, Cardiol Therapeutics Inc. is publicly traded under the ticker symbol CRDL on the NCM. The company has a market capitalization of approximately $0.10 billion.

Where is Cardiol Therapeutics Inc. headquartered?

Cardiol Therapeutics Inc. is headquartered in Oakville, ON, United States at 2265 Upper Middle Road East, Oakville, ON L6H 0G5, Canada.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.